Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AccessOne is a U.S. healthcare fintech company focused on patient payment and financing solutions for hospitals and health systems. Its platform helps providers collect patient balances through mobile-first payment workflows, automation, digitization, text-to-pay capabilities, and extended repayment plans including 0% interest options for eligible programs. The company positions itself around improving the patient financial experience while supporting provider reimbursement and reducing bad debt risk. AccessOne is not a drug developer or therapeutic company; it operates in healthcare administration and payments infrastructure. In 2025, Phreesia agreed to acquire AccessOne Parent Holdings for approximately $160 million, and transaction databases indicate the acquisition was completed in November 2025.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AccessOne.